Thrive Bioscience Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Thrive Bioscience Inc.
Medtech Insight spoke with Stephen Hahn, ex-FDA commissioner and CEO of Harbinger Health, who attended SXSW, about the firm’s blood-based cancer test in development.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced August through September 2015.
Brief profiles of these recently formed companies: CaveoMed, Checkmate, Metacrine, and Thrive Bioscience.
Brief profiles of these recently formed companies: CaveoMed, Checkmate Pharmaceuticals, Metacrine and Thrive Bioscience.
- Laboratory Testing Services
- Research, Analytical Equipment & Supplies
- Other Names / Subsidiaries
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.